-

Piper Sandler Launches Private Markets Trading with Three Key Hires

MINNEAPOLIS--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the launch of private markets trading with three new hires. Patrick Gordon, Kyle Mooney and David Ilishah have joined the firm as managing directors and will be focused on trading equity shares of private companies.

“As companies stay private for longer, demand for trading in private shares has grown significantly. We are thrilled to have Patrick, Kyle and David join the firm to lead this initiative," said Deb Schoneman.

Share

“As companies stay private for longer, demand for trading in private shares has grown significantly. We are thrilled to have Patrick, Kyle and David join the firm to lead this initiative. Their deep experience and strong relationships across private companies and alternative managers will expand opportunities we can offer our clients to invest in high-growth private businesses or to monetize illiquid positions before they go public,” said Deb Schoneman, president at Piper Sandler.

All three hires join Piper Sandler from Forge Global. Mooney was a managing director and Gordon and Ilishah were senior directors in the Private Capital Markets group. Collectively the team brings nearly 20 combined years in the private securities business, where they have executed a broad range of transaction types primarily focused on venture secondaries and single-asset LP transfers.

Gordon, Mooney and Ilishah commented, “The private market has experienced exponential growth over the past five years as companies tap deeper pools of private capital and alternative funding. Piper Sandler has a longstanding reputation as a trusted leader in private placements and equity capital markets. The firm is uniquely positioned to deliver liquidity solutions for their existing clients and expand their equities product offering with this new capability. We are excited to hit the ground running and build this line of business.”

ABOUT PIPER SANDLER

Piper Sandler Companies (NYSE: PIPR) is a leading investment bank driven to help clients Realize the Power of Partnership®. Securities brokerage and investment banking services are offered in the U.S. through Piper Sandler & Co., member SIPC and NYSE; in the U.K. through Piper Sandler Ltd., authorized and regulated by the U.K. Financial Conduct Authority; in the EU through Aviditi Capital Advisors Europe GmbH, authorized and regulated by BaFin as a tied agent of AHP Capital Management GmbH; and in Hong Kong through Piper Sandler Hong Kong Limited, authorized and regulated by the Securities and Futures Commission. Alternative asset management and fixed income advisory services are offered through separately registered advisory affiliates.

Follow Piper Sandler: LinkedIn | Facebook | X

©2025. Since 1895. Piper Sandler Companies. 350 North 5th Street, Minneapolis, Minnesota 55401

Contacts

Nick Lawler
Tel: 212 891-8954
nick.lawler@psc.com

Piper Sandler Companies

NYSE:PIPR

Release Versions

Contacts

Nick Lawler
Tel: 212 891-8954
nick.lawler@psc.com

More News From Piper Sandler Companies

Piper Sandler Appoints Aamer Naseer to Head of Life Sciences Outsourcing and B2B Med Tech

MINNEAPOLIS--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the appointment of Aamer Naseer to global head of life sciences outsourcing and B2B med tech. “Aamer has built deep relationships across the life sciences ecosystem and has a strong track record of advising private equity firms, public companies and founders/entrepreneurs. His leadership, sector expertise and commitment to our clients position us exceptionally well to continue e...

Piper Sandler Strengthens Healthcare Investment Banking Team with the Addition of Jason Arnold

MINNEAPOLIS & LONDON--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Jason Arnold as a managing director in the healthcare investment banking group. Arnold will be initially based in London while serving clients globally. He will be advising life science tools and diagnostic companies on mergers and acquisitions, strategic partnerships and capital raising transactions. “We’re delighted to welcome Jason to the healthcare i...
Back to Newsroom